ClinicalTrialsFinder

PD-1/CTLA-4 Clinical Trials in Shijiazhuang, Hebei

1 recruitingShijiazhuang, Hebei, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)

ImmunotherapyAFP Gastric or Gastroesophageal Junction AdenocarcinomaPD-1/CTLA-4+1 more
Hebei Medical University Fourth Hospital39 enrolled1 locationNCT07289997